节点文献

血管内皮生长因子检测试剂盒的研制

Development of the vascular endothelial growth factor assay kit

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 李树香; 王欣怡; 刘敬; 周亚; 徐静; 邹剑平;

【Author】 LI Shu-xiang1,WANG Xin-yi1,LIU Jing1,ZHOU Ya1,XU Jing1,ZOU Jian-ping2 (1.National Vaccine and Serum Institute,Beijing 100024,China; 2.Beijing Jianping Jiuxing Biomedical Science and Technology Co.,Ltd.,Beijing 100085,China)

【机构】 北京生物制品研究所 第三研究室; 北京健平九星生物医药科技有限公司;

【摘要】 目的:研制血管内皮生长因子检测试剂盒(酶标法),用于类风湿性关节炎的临床诊断。方法:以~株抗血管内皮生长因子特异性单克隆抗体作为捕获抗体,另一株单抗作为检测抗体,棋盘滴定确定抗体使用浓度。制备VEGF165参考品,对样品稀释液、封闭液等实验条件进行优化。对试剂盒进行分析性能评估确定其质控标准。通过临床试验验证其在类风湿性关节炎检测中的有效性。结果:棋盘滴定确定捕获抗体浓度为10μg/mL,酶标抗体1;20 000应用,冻干VECF165参考品含量720~880 pg/mL,变异系数<10%。5%BSA作为封闭液和样品稀释液,试剂盒线性范围0~400 pg/mL,最低检出量0 pg/mL,不同浓度样本批内精密度9.83%~13.73%,不同时间批内精密度5.47%~14.08%,批间精密度7.88%,准确性94%~105%,特异性良好,效期末产品各项指标符合标准。确定了正常人VEGF参考范围:<142.2 pg/mL,作为判断类风湿性关节炎活动期指标灵敏度为70.5%,特异性80%。结论:成功研制了血管内皮生长因子检测试剂盒,完成临床试验评价。

【Abstract】 Objective:To develop a vascular endothelial growth factor assay kit for clinical diagnosis of rheumatoid arthritis.Methods:We choose two anti-vascular endothelial growth factor monoclonal antibodies as capture antibody and detective antibody respectively and determined the concentration of antibodies used by checkboard titration.To prepare freeze-dried VEGF165 reference material.The sample diluention,blocking solution and other experimental conditions were optimized.To determine the quality control standards by performance evaluation.Verify the effectiveness for RA detection through clinical trials.Results:The concentration of capture antibody and detect antibody were indentified as 10μg/mL and 1:20 000 respectively.The content of freeze-dried reference material is 720~880 pg/mL.Coefficient of variation is less than 10%.The sample diluent and block solution was 5%BSA.The linear range is 0~400 pg/mL.The minimum detectable concentration is 0 pg/mL.The intra precision of different concentration samples is 9.8%~13.7%.The intra precision of different detection times is 5.4%~14%.The inter precision is 7.8%.The precision performance is 94%~105%.Not found cross reaction with other cytokines.The Indicators of effective product at the end meet quality control standards.Normal reference values of VEGF:<142.2 pg/mL.As an indicator of active rheumatoid arthritis,sensitivity is 70.5%.Specificity is 80%.Conclusion:The vascular endothelial growth factor assay kit was successfully prepared. Evaluation of clinical trials completed.

  • 【会议录名称】 2011中国生物制品年会暨第十一次全国生物制品学术研讨会论文集
  • 【会议名称】2011中国生物制品年会暨第十一次全国生物制品学术研讨会
  • 【会议时间】2011-09-21
  • 【会议地点】中国四川成都
  • 【分类号】R392.1
  • 【主办单位】中华预防医学会生物制品分会
节点文献中: